Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mercaptomethyl phosphonate is a small molecule organophosphonate compound featuring both a mercapto (thiol, –SH) and a phosphonate group. It has the molecular formula CH3O3PS and a molecular weight of approximately 126.07 g/mol[1][2][3]. This compound is primarily used as an experimental chemical probe in biochemical research rather than as an approved pharmaceutical drug. Notably, it acts as a competitive inhibitor of alkaline phosphatase enzymes, binding to the active site and interfering with enzyme activity[8]. Its inhibitory effect has been characterized structurally in complex with Escherichia coli alkaline phosphatase, where it binds with its phosphonate moiety directed toward solvent rather than coordinating directly to active site zinc ions[8]. There are no known clinical indications or therapeutic uses for this compound; it is not approved for medical use in any jurisdiction[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on mercaptomethyl phosphonate.